Celltrion Healthcare Canada Ltd. Announces the Opening of a New Office in Montreal, Strengthening its Growing Presence in Quebec

MONTREAL, Oct. 22, 2026 /CNW/ -- Celltrion, a South Korean biopharmaceutical company recognized globally for the development and commercialization of innovative biologics and biosimilars, today announced the official opening of its new office in Montreal. This establishment marks a key step in Celltrion's strategic expansion in Quebec and demonstrates the company's commitment to sustainably growing its presence in the province.

The opening of this office supports Celltrion's rapid growth in North America and reflects Quebec's growing importance as a strategic hub for life sciences and biopharmaceutical innovation. Montreal, with its dynamic research ecosystem, highly skilled talent and international positioning, represents an ideal location to support the company's ambitions.

"The opening of our office in Montreal is a major step in our establishment in Quebec. It confirms our desire to get closer to local partners, to better understand the needs of patients and healthcare professionals in the province, and to actively contribute to the Quebec life sciences ecosystem," said Jung Yong Shin, General Manager, Celltrion.

Celltrion Healthcare Canada Ltd., the division responsible for the global distribution of the group's products, providing innovative and affordable medicines to improve patient access to cutting-edge therapies. Celltrion's products are manufactured in state-of-the-art mammalian cell culture facilities that meet Health Canada, U.S. FDA (cGMP) and EU guidelines (GMP) standards. With an extensive global network spanning more than 110 countries, Celltrion provides high-quality, cost-effective solutions to healthcare systems around the world.

SOURCE Celltrion Healthcare Canada Ltd.

Media Contact: Jeeyoung Kim, Alliance Manager, Celltrion Healthcare Canada Ltd., 121 King Street West, Suite (bureau) #1110, Toronto, Ontario, Canada, M5H 3T9, Mobile: [phone], E-mail: [email protected]; Karl Désy, National Market Access & stakeholder manager, 2001 Robert-Bourassa Boulevard, Montréal, QC, H3A 2A6, Tel: [phone], Email: [email protected]